SlideShare ist ein Scribd-Unternehmen logo
1 von 78
Downloaden Sie, um offline zu lesen
Presented by Dr Rohit Rao
• Phakomatoses derived from Greek word
phakomata or birth mark
• Syndromes characterized by hamartomas of
the skin, eye, central nervous system (CNS),
and other viscera are collectively called
Phacomatosis
Phacomatoses
• Neurofibromatosis type 1 (NF1), the most
common type,von Recklinghausen's
neurofibromatosis or peripheral
neurofibromatosis.
• Neurofibromatosis type 2 (NF2) or central or
bilateral acoustic neurofibromatosis.
Neurofibromatosis Type 1
• Most common phacomatosis
• autosomal-dominant disorders.
• The gene involved in NF1 is on chromosome
17 (17q11.2).
• It encodes for neurofibromin, a tumour
suppressor
Phacomatoses
Clinical Features
• Cutaneous Findings
• Café-au-lait spots and other hyperpigmented
skin lesions seen in 99% of adults with NF1.
РCaf̩-au-lait spots are pigmented, flat (macular)
skin lesions typically with smooth edges.
– Present at birth, they increase in size and number.
• Other pigmented lesions include freckles
(lentigines)
• These areas of hyperpigmentation are present
in axilla or groin.
• Neurofibromas are benign nerve sheath tumors
consisting of Schwann cells, fibroblastic
elements, and embedded axons.
– Solitary neurofibromas
• Located on skin, especially on trunk, & face.
• Arise in deep peripheral nerves, spinal nerve roots, and
autonomic nerves of blood vessels.
– Multiple neurofibromas are pathognomonic of NF1.
– Plexiform neurofibroma, diffuse mass with extensive
interdigitations with surrounding tissue.
Multiple neurofibromas
Plexiform neurofibroma
Ocular Findings
Phacomatoses
•Congenital glaucoma associated with upper eyelid
neurofibroma.
–Gonioscopy shows iris insertion anterior to scleral
spur.
–Angle appears to be covered by a membrane.
•Optic nerve gliomas are pilocytic hamartomas of anterior
visual pathways.
–Bilateral optic nerve gliomas are pathognomonic of
NF1.
•Pulsatile exophthalmos due to sphenoid dysplasia .
•Prominent corneal nerves.
•Conjunctival and scleral neurofibroma are rare.
Phacomatoses
Phacomatoses
Phacomatoses
MANAGEMENT
• Patients need detailed counseling regarding the
prognosis, genetic, and psychological aspects of
disease.
• First-degree relatives should be evaluated.
• Malignant tumors : excision, chemotherapy,
and/or radiotherapy may be indicated.
• Management of optic nerve glioma remains
controversial.
–Therapeutic indication and outcomes with
various forms of treatment include
observation, chemotherapy, excision, and
radiotherapy.
• Long-term follow- up shows a good prognosis.
• Chemotherapy may stabilize vision or induce
tumor regression in more than 50% of cases.
NEUROFIBROMATOSIS TYPE 2
• Central NF
• Unlike NF1,cutaneous findings are not
predominant .
• Schwannomas are the characteristic tumors of
NF2.
• Autosomal dominant
• About 50% of cases represent new mutations.
• Chromosome 22q12.
– It encodes a protein known as schwannomin
Phacomatoses
Phacomatoses
SYSTEMIC FINDINGS
• Bilateral vestibular schwannomas (VS) are
diagnostic of NF 2.
• The mean age at onset of VS is less than 25 years
• Symptoms of NF2 are due to VS rather than to
ocular involvement.
– Deafness with or without tinnitus is most common.
Seizures, vertigo, and numbness are less common.
– Blindness occurs as presenting symptom in only 1% of
cases.
• Spinal schwannomas are present in more than
75% of the cases with NF2.
• Additionally, intracranial or optic nerve
meningiomas and spinal ependymomas are
also observed.
Phacomatoses
OPHTHALMIC FINDINGS
• Posterior subcapsular cataract or wedge
cortical cataracts.
• Retinal hamartoma and combined
hamartomas of the retina and retinal pigment
epithelium (RPE).
• Rarely Lisch nodules
Wedge cortical cataracts
Combined hamartomas of
RPE and retina
MANAGEMENT
• Patients should be screened by neurologic,
ophthalmic, and neuro-otologic testing.
• MRI (contrast-enhanced, multi planar T1- weighted)
is a cost-effective first-line investigation in
detection of VS.
• Majority (90%) of patientspresent with bilateral VS.
• Management of VS include observation,
stereotactic radiotherapy, and surgical resection.
VON HIPPEL–LINDAU DISEASE
• Eugen von Hippel, a German ophthalmologist,
coined the term angiomatosis retinae in 1904.
• Arvid Lindau, a Swedish pathologist,
established a relationship between cerebellar
and retinal hemangioblastomas
• Autosomal dominant
• VHL gene on chromosome 3p25-26
Phacomatoses
SYSTEMIC FINDINGS
• VHL disease is a multisystem disorder with a
predilection for the retina and CNS.
• Retinal capillary hemangiomas (RCH) occur in ‹
75% of cases, CNS hemangiomas in more than
50%, renal carcinomas in ‹ 50% , and
pheochromocytomas in ‹ 25%.
• Probability of developing any components of
disease increases with age.
• Central nervous system hemangioma commonly
involve cerebellum (75%) and spinal cord (15%).
• Tend to be multiple and occur at a younger age as
compared to sporadic cases.
• Headache is initial symptom of cerebellar
hemangiomas and pain is common symptom of
spinal cord hemangiomas.
Phacomatoses
• Renal cell carcinoma is leading cause of
mortality.
– Bilateral in 93% of cases; multiple, renal cysts, and
occur at younger age compared to sporadic cases.
• Pheochromocytomas, rare benign tumors of
adrenal medulla, tend to be multiple and
bilateral.
– Elevated serum levels of catecholamines
(norepinephrine and epinephrine) that lead to
symptoms such as palpitations, headaches, and
sweating.
Phacomatoses
OPHTHALMOLOGIC FINDINGS
• Retinal capillary hemangioma (RCH) is one of the
most common manifestations
• Circumscribed, round retinal lesion with an
orange-red color with prominent feeder vessels.
• Presence of multiple RCH (two or more), other
manifestations of VHL disease, or a positive
family history are diagnostic of underlying VHL
disease.
Phacomatoses
MANAGEMENT
• Treatment of RCH determined by size,
location, and associated subretinal fluid,
retinal traction, and visual potential of eye.
• Retinal angiomas can be effectively treated
with cryotherapy or laser photocoagulation
• Early diagnosis increases the likelihood of
successful treatment yet the ocular lesions are
asymptomatic prior to RD.
• Should undergo periodic ophthalmologic
evaluation beginning at about age 5 years.
• Life expectancy may be improved by early
detection and treatment of various tumors.
TUBEROUS SCLEROSIS
• Coined by Desire Magloire Bourneville
(1840–1909), a French physician.
• He described a patient with seizures, hemiplegia,
mental subnormality, and renal tumors.
• He based the terminology tuberous sclerosis, on
multiple potato-like (tubers) lesions in the brain
GENETICS
• Tuberous sclerosis complex (TSC) includes two
genetic diseases (TSC1 and TSC2) with autosomal
dominant inheritance or sporadic.
• The genes responsible for TSC, TSC1
(chromosome 9q34)71 and TSC2,72 have now
been identified.
• TSC1 and TSC2 genes, encode the proteins
hamartin and tuberin, respectively.
Phacomatoses
SYSTEMIC FINDINGS
• Characterized by hamartomas of various
organs.
• Hamartomas in the brain (astrocytoma and
ependymoma) lead to childhood seizures and
mental retardation.
• Clinical manifestations of TSC1 and TSC2 are
similar except that the TSC1 is milder with a
reduced risk of mental retardation as
compared to TSC2.
• Other findings of TSC1 such as seizures, renal
involvement, facial angiofibroma, and retinal
hamartomas are also less frequent or less
severe compared to TSC2.
• Cutaneous manifestations of TSC are mainly
of diagnostic significance.
– Hypomelanotic macules are the most frequent
and the earliest finding, best visualized with
Wood’s lamp (UV light).
– Fibrous plaques appear as reddish-orange
patches on the forehead.
– Facial angiofibromas are not present at birth
and appear usually by age 5 years.
Shagreen patches
Subungual
fibromas
Hypomelanotic macules
Phacomatoses
• Visceral manifestations include pulmonary
lymphangiomyomatosis, renal
angiomyolipoma, and cardiac rhabdomyoma
• Imaging studies such as MRI of brain and CT -
abdomen are important to detect CNS and
visceral involvement.
• OPHTHALMOLOGIC FINDINGS
• Retinal or Optic nerve hamartomas
• Three morphologic types of retinal astrocytic
hamartomas are opthlamoscopically recognized:
1. More common subtle, flat, round, semitranslucent
lesion;
2. Large, elevated, nodular, and calcified mulberry
lesion;
3. Mixed type of lesion, being calcified in the central
portion and semitranslucent in the periphery.
Phacomatoses
MANAGEMENT
• Depends upon location & extent of organ
involvement.
• Retinal astrocytic hamartomas usually need
only periodic evaluation by ophthalmoscopy
and fundus photography.
• Patients with TSC-related mental retardation
require supervision for daily living.
• Common causes of mortality are renal
disease, brain tumors and status epilepticus.
• Patients need lifelong follow-up for early
detection of potentially life threatening
complications.
Phacomatoses
• Sturge (1879) reported the case of a child with
facial “port-wine stain,” epilepsy,
buphthalmos, and a dark choroid.
• Schirmer had noted the association with
glaucoma in 1860.
• Weber (1922) reported brain X-ray findings of
“railtrack” sign
SYSTEMIC FINDINGS
• Predominant manifestation is a diffuse
hemangioma in leptomeninges, choroid, and
facial skin.
• Sturge–Weber syndrome with its neural
involvement leads to intractable seizures,
developmental delay, and behavioral
problems.
• Cutaneous manifestations of nevus flammeus,
although most evident, are mainly of
diagnostic significance,
• Glaucoma and diffuse choroidal hemangioma
may be associated with some visual loss.
• Leptomeningeal hemangiomatosis is ipsilateral to
cutaneous involvement.
–This can lead to a seizure disorder due to
effects on underlying cerebral cortex.
–Contrast-enhanced MRI for detecting cerebral
atrophy and leptomeningeal angiomatous
malformations.
–If MRI is normal, CT scan to detect intracranial
calcifications.
Phacomatoses
• Cutaneous hemangioma is also called nevus flammeus
or port wine stain.
– Only 10% are associated with SWS.
– SWS only occurs in patients with, involvement of V1
or V2 distribution of trigeminal nerve.
– Bilateral port wine stains have higher associatpon.
• Leptomeningeal and ocular involvement in SWS are
always associated with port wine stain involving eyelids.
Phacomatoses
OPHTHALMOLOGIC FINDINGS
• Glaucoma is the most frequent manifestation
of SWS and occurs in 70% of all cases.
• Angle maldevelopment or raised episcleral
venous pressure can lead to glaucoma.
• Incidence of glaucoma is higher if the eyelids
are involved with nevus flammeus.
• Choroidal hemangioma is usually unilateral
and ipsilateral to the nevus flammeus.
– Appears as an orange-colored, diffuse choroidal
thickening associated with exudative RD.
Phacomatoses
MANAGEMENT
• Medical therapy of glaucoma is effective in some
cases, but eventually require multiple
trabeculectomies combined trabeculotomy with
trabeculectomy, or even drainage implants.
• Choroidal hemangioma can be treated with low-
dose standard radiotherapy or with proton beam
radiotherapy.
• Seizures are generally controlled with medications
but intractable cases require surgical resection of
leptomeningeal angiomatosis with underlying
cerebral cortex.
Phacomatoses
• Madame Louis-Bar in 1941 described a young
boy with progressive cerebellar ataxia and
oculocutaneous telangiectasia.
• Term ‘ataxia telangiectasia’ was proposed by
Boder and Sedgwick in 1958
• Autosomal recessive.
• Causative gene in AT is called ATM (ataxia -
telangiectasia mutated gene) and is found on
chromosome llq22.3.
SYSTEMIC FINDINGS
• Childhood neurodegenerative disorder with
neural, ocular, and cutaneous manifestations
associated with immune dysfunction.
• Progressive cerebellar ataxia in early childhood is
hallmark of AT
• Show increased sensitivity to the tissue-damaging
side effects of therapeutic radiation and
chemotherapeutic agents.
• Defective T-cell function associated with
hypoplasia of the thymus and decreased levels of
circulating immunoglobulin.
• Recurrent respiratory tract infections are a
serious problem,
• Increased susceptibility to various malignancies,
particularly lymphomas and leukemias,
contributes to early mortality.
Ocular findings
• Telangiectasia of conjunctiva has later onset than
ataxia and appears at age 3-7 years.
• First noted in the interpalpebral bulbar
conjunctiva away from limbus.
• Later ocular telangiectasia becomes generalized
and simulates a conjunctivitis.
• Ocular abnormalities include oculomotor
apraxia, deficient accommodation, impaired
smooth pursuit, hypometric saccades,nystagmus,
absence of optokinetic nystagmus, frequent
blinking.
• Combination of oculomotor apraxia and failure
to suppress the vestibulo-ocular reflex is
characteristic.
• Patients will develop impairment of pursuits
by school age.
• Increased saccadic latency, saccadic
hypometria, and saccadic intrusions are also
seen.
• Visual acuity, pupillary response, and
funduscopic examination are usually normal.
MANAGEMENT
• AT patients suffer from recurrent sino-
pulmonary infections because of immune
dysfunction.
• AT-associated malignancies such as lymphoma
and leukemia require modified chemotherapy
and radiotherapy dosages because of
hypersensitivity to radiation and
chemotherapy-induced DNA damage.
Phacomatoses

Más contenido relacionado

Was ist angesagt?

Neurocutaneous syndromes
Neurocutaneous syndromesNeurocutaneous syndromes
Neurocutaneous syndromesdrnaveent
 
Choroidal melanoma
Choroidal melanoma Choroidal melanoma
Choroidal melanoma SSSIHMS-PG
 
Phakomatoses(Ophthalmology)
Phakomatoses(Ophthalmology)Phakomatoses(Ophthalmology)
Phakomatoses(Ophthalmology)Shylesh Dabke
 
Ocular surface squamous neoplasia
Ocular surface squamous neoplasiaOcular surface squamous neoplasia
Ocular surface squamous neoplasiaRuchi sood
 
Choroidal melanoma
Choroidal melanomaChoroidal melanoma
Choroidal melanomaSSSIHMS-PG
 
Sturge weber syndrome
Sturge weber syndromeSturge weber syndrome
Sturge weber syndromeAnurag Pikle
 
Pneumatic retinopexy
Pneumatic retinopexyPneumatic retinopexy
Pneumatic retinopexyNikhil Rp
 
Orbital Rhabdomyosarcoma
Orbital RhabdomyosarcomaOrbital Rhabdomyosarcoma
Orbital RhabdomyosarcomaHimanshu Soni
 
Orbital tumours
Orbital tumoursOrbital tumours
Orbital tumoursairwave12
 
Anatomy and Visual field defects of optic nerve and chiasma
Anatomy and Visual field defects of optic nerve and chiasmaAnatomy and Visual field defects of optic nerve and chiasma
Anatomy and Visual field defects of optic nerve and chiasmaSadhwini Harish
 
Central retinal vein occlusion CRVO
Central retinal vein occlusion CRVOCentral retinal vein occlusion CRVO
Central retinal vein occlusion CRVODr. Md. Suzon Islam
 
Amaurosis Fugax
Amaurosis FugaxAmaurosis Fugax
Amaurosis FugaxAde Wijaya
 
Orbital And Peri Orbital Tumours
Orbital And Peri Orbital TumoursOrbital And Peri Orbital Tumours
Orbital And Peri Orbital Tumoursfondas vakalis
 

Was ist angesagt? (20)

Neurocutaneous syndromes
Neurocutaneous syndromesNeurocutaneous syndromes
Neurocutaneous syndromes
 
Choroidal melanoma
Choroidal melanoma Choroidal melanoma
Choroidal melanoma
 
Phakomatoses(Ophthalmology)
Phakomatoses(Ophthalmology)Phakomatoses(Ophthalmology)
Phakomatoses(Ophthalmology)
 
Ocular surface squamous neoplasia
Ocular surface squamous neoplasiaOcular surface squamous neoplasia
Ocular surface squamous neoplasia
 
Choroidal melanoma
Choroidal melanomaChoroidal melanoma
Choroidal melanoma
 
Intraocular tumors
Intraocular tumorsIntraocular tumors
Intraocular tumors
 
Sturge weber syndrome
Sturge weber syndromeSturge weber syndrome
Sturge weber syndrome
 
Phakomatoses
PhakomatosesPhakomatoses
Phakomatoses
 
Pneumatic retinopexy
Pneumatic retinopexyPneumatic retinopexy
Pneumatic retinopexy
 
Sturge weber syndrome
Sturge weber syndromeSturge weber syndrome
Sturge weber syndrome
 
Orbital Rhabdomyosarcoma
Orbital RhabdomyosarcomaOrbital Rhabdomyosarcoma
Orbital Rhabdomyosarcoma
 
Orbital tumours
Orbital tumoursOrbital tumours
Orbital tumours
 
Oct in glaucoma
Oct in glaucomaOct in glaucoma
Oct in glaucoma
 
Anatomy and Visual field defects of optic nerve and chiasma
Anatomy and Visual field defects of optic nerve and chiasmaAnatomy and Visual field defects of optic nerve and chiasma
Anatomy and Visual field defects of optic nerve and chiasma
 
Central retinal vein occlusion CRVO
Central retinal vein occlusion CRVOCentral retinal vein occlusion CRVO
Central retinal vein occlusion CRVO
 
ocular Sarcoidosis
ocular Sarcoidosisocular Sarcoidosis
ocular Sarcoidosis
 
CRVO
CRVOCRVO
CRVO
 
Proptosis in ophthalmology
Proptosis  in ophthalmologyProptosis  in ophthalmology
Proptosis in ophthalmology
 
Amaurosis Fugax
Amaurosis FugaxAmaurosis Fugax
Amaurosis Fugax
 
Orbital And Peri Orbital Tumours
Orbital And Peri Orbital TumoursOrbital And Peri Orbital Tumours
Orbital And Peri Orbital Tumours
 

Ähnlich wie Phacomatoses

Neurocutaneous syndrome.pptx
Neurocutaneous syndrome.pptxNeurocutaneous syndrome.pptx
Neurocutaneous syndrome.pptxNeerajOjha17
 
Neurocutaneous syndrome
Neurocutaneous syndromeNeurocutaneous syndrome
Neurocutaneous syndromeazmery saima
 
Neurocutaneous syndromes.pptx
Neurocutaneous syndromes.pptxNeurocutaneous syndromes.pptx
Neurocutaneous syndromes.pptxxerit31073
 
Neurocutaneous Syndrome - by MHR Corporation
Neurocutaneous Syndrome - by MHR CorporationNeurocutaneous Syndrome - by MHR Corporation
Neurocutaneous Syndrome - by MHR CorporationMohd Hanafi
 
Neurocutaneous Disorders Walid Reda Ashour Egypt
Neurocutaneous Disorders Walid Reda Ashour  EgyptNeurocutaneous Disorders Walid Reda Ashour  Egypt
Neurocutaneous Disorders Walid Reda Ashour EgyptWalid Reda Ashour
 
Neurocutaneous Syndromes
Neurocutaneous SyndromesNeurocutaneous Syndromes
Neurocutaneous SyndromesNishant Yadav
 
Imaging in Phakomatoses
Imaging in Phakomatoses Imaging in Phakomatoses
Imaging in Phakomatoses Nikhil Mehta
 
Acute disseminated encephalomyelitis
Acute disseminated encephalomyelitis Acute disseminated encephalomyelitis
Acute disseminated encephalomyelitis Reyad Al_Faky
 
Tuberous sclerosis
Tuberous sclerosisTuberous sclerosis
Tuberous sclerosisamol lahoti
 
Neuromyelitis Optica
Neuromyelitis OpticaNeuromyelitis Optica
Neuromyelitis Opticasm171181
 
Neurofibromatosis.pptx
Neurofibromatosis.pptxNeurofibromatosis.pptx
Neurofibromatosis.pptxAkshaySarraf1
 
Neurofibromatosis
NeurofibromatosisNeurofibromatosis
NeurofibromatosisDR.
 

Ähnlich wie Phacomatoses (20)

Neurocutaneous syndrome.pptx
Neurocutaneous syndrome.pptxNeurocutaneous syndrome.pptx
Neurocutaneous syndrome.pptx
 
Neurocutaneous syndromes
Neurocutaneous syndromesNeurocutaneous syndromes
Neurocutaneous syndromes
 
Neurocutaneous syndrome
Neurocutaneous syndromeNeurocutaneous syndrome
Neurocutaneous syndrome
 
Neurocutaneous syndromes.pptx
Neurocutaneous syndromes.pptxNeurocutaneous syndromes.pptx
Neurocutaneous syndromes.pptx
 
Neurocutaneous Syndrome - by MHR Corporation
Neurocutaneous Syndrome - by MHR CorporationNeurocutaneous Syndrome - by MHR Corporation
Neurocutaneous Syndrome - by MHR Corporation
 
Neurocutaneous Disorders Walid Reda Ashour Egypt
Neurocutaneous Disorders Walid Reda Ashour  EgyptNeurocutaneous Disorders Walid Reda Ashour  Egypt
Neurocutaneous Disorders Walid Reda Ashour Egypt
 
Neurocutaneous Syndromes
Neurocutaneous SyndromesNeurocutaneous Syndromes
Neurocutaneous Syndromes
 
Imaging in Phakomatoses
Imaging in Phakomatoses Imaging in Phakomatoses
Imaging in Phakomatoses
 
Neurofibromatosis abhijeet
Neurofibromatosis abhijeetNeurofibromatosis abhijeet
Neurofibromatosis abhijeet
 
Neurocutaneous
Neurocutaneous  Neurocutaneous
Neurocutaneous
 
NCS
NCSNCS
NCS
 
Acute disseminated encephalomyelitis
Acute disseminated encephalomyelitis Acute disseminated encephalomyelitis
Acute disseminated encephalomyelitis
 
ADEM.pdf
ADEM.pdfADEM.pdf
ADEM.pdf
 
Tuberous sclerosis
Tuberous sclerosisTuberous sclerosis
Tuberous sclerosis
 
Neuromyelitis Optica
Neuromyelitis OpticaNeuromyelitis Optica
Neuromyelitis Optica
 
Genodermatosis
GenodermatosisGenodermatosis
Genodermatosis
 
NEUROCUTANEOUS SYNDROME
NEUROCUTANEOUS SYNDROMENEUROCUTANEOUS SYNDROME
NEUROCUTANEOUS SYNDROME
 
Neurocutaneous syndrome
Neurocutaneous syndromeNeurocutaneous syndrome
Neurocutaneous syndrome
 
Neurofibromatosis.pptx
Neurofibromatosis.pptxNeurofibromatosis.pptx
Neurofibromatosis.pptx
 
Neurofibromatosis
NeurofibromatosisNeurofibromatosis
Neurofibromatosis
 

Mehr von Rohit Rao

Yag capsulotomy
Yag capsulotomyYag capsulotomy
Yag capsulotomyRohit Rao
 
Types of iol
Types of iolTypes of iol
Types of iolRohit Rao
 
Thyroid eye diseases
Thyroid eye diseases   Thyroid eye diseases
Thyroid eye diseases Rohit Rao
 
Pcr managment
Pcr managmentPcr managment
Pcr managmentRohit Rao
 
Orbital apex syndrome
Orbital apex syndromeOrbital apex syndrome
Orbital apex syndromeRohit Rao
 
Defects of visual pathway
Defects of visual pathwayDefects of visual pathway
Defects of visual pathwayRohit Rao
 
Basic principles of ocular ultrasonography
Basic principles of ocular ultrasonographyBasic principles of ocular ultrasonography
Basic principles of ocular ultrasonographyRohit Rao
 
retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurityRohit Rao
 
Peripheral fundus & its disorders
Peripheral fundus & its disordersPeripheral fundus & its disorders
Peripheral fundus & its disordersRohit Rao
 
anatomy and physiology of lacrimal apparatus ppt
anatomy and physiology of lacrimal apparatus  pptanatomy and physiology of lacrimal apparatus  ppt
anatomy and physiology of lacrimal apparatus pptRohit Rao
 
Hess charting
Hess chartingHess charting
Hess chartingRohit Rao
 
Physiology of aqueous humor
Physiology of aqueous humorPhysiology of aqueous humor
Physiology of aqueous humorRohit Rao
 
Accommodation of eye
Accommodation of eye Accommodation of eye
Accommodation of eye Rohit Rao
 
Confocal microscopy of the eye
Confocal microscopy of the eyeConfocal microscopy of the eye
Confocal microscopy of the eyeRohit Rao
 

Mehr von Rohit Rao (18)

Biometery
Biometery Biometery
Biometery
 
Yag capsulotomy
Yag capsulotomyYag capsulotomy
Yag capsulotomy
 
Uveitis
UveitisUveitis
Uveitis
 
Types of iol
Types of iolTypes of iol
Types of iol
 
Thyroid eye diseases
Thyroid eye diseases   Thyroid eye diseases
Thyroid eye diseases
 
Pcr managment
Pcr managmentPcr managment
Pcr managment
 
Orbital apex syndrome
Orbital apex syndromeOrbital apex syndrome
Orbital apex syndrome
 
Defects of visual pathway
Defects of visual pathwayDefects of visual pathway
Defects of visual pathway
 
Basic principles of ocular ultrasonography
Basic principles of ocular ultrasonographyBasic principles of ocular ultrasonography
Basic principles of ocular ultrasonography
 
Optic nerve
Optic nerveOptic nerve
Optic nerve
 
retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
 
Peripheral fundus & its disorders
Peripheral fundus & its disordersPeripheral fundus & its disorders
Peripheral fundus & its disorders
 
anatomy and physiology of lacrimal apparatus ppt
anatomy and physiology of lacrimal apparatus  pptanatomy and physiology of lacrimal apparatus  ppt
anatomy and physiology of lacrimal apparatus ppt
 
Hess charting
Hess chartingHess charting
Hess charting
 
Astigmatism
AstigmatismAstigmatism
Astigmatism
 
Physiology of aqueous humor
Physiology of aqueous humorPhysiology of aqueous humor
Physiology of aqueous humor
 
Accommodation of eye
Accommodation of eye Accommodation of eye
Accommodation of eye
 
Confocal microscopy of the eye
Confocal microscopy of the eyeConfocal microscopy of the eye
Confocal microscopy of the eye
 

Último

airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptxnakera38
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedSBL DIGITAL
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxSizan Thapa
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......anupamdas2143
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdfHongBiThi1
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxVeereshDemashetti
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionZeinabEmad3
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeQuick MedTalk
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
clean rooms and its classification .pptx
clean rooms and its classification .pptxclean rooms and its classification .pptx
clean rooms and its classification .pptxushakiranmai4
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Dr. Dheeraj Kumar
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdfHongBiThi1
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 

Último (20)

airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptx
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limited
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptx
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptx
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), Addiction
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
clean rooms and its classification .pptx
clean rooms and its classification .pptxclean rooms and its classification .pptx
clean rooms and its classification .pptx
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 

Phacomatoses

  • 1. Presented by Dr Rohit Rao
  • 2. • Phakomatoses derived from Greek word phakomata or birth mark • Syndromes characterized by hamartomas of the skin, eye, central nervous system (CNS), and other viscera are collectively called Phacomatosis
  • 4. • Neurofibromatosis type 1 (NF1), the most common type,von Recklinghausen's neurofibromatosis or peripheral neurofibromatosis. • Neurofibromatosis type 2 (NF2) or central or bilateral acoustic neurofibromatosis.
  • 5. Neurofibromatosis Type 1 • Most common phacomatosis • autosomal-dominant disorders. • The gene involved in NF1 is on chromosome 17 (17q11.2). • It encodes for neurofibromin, a tumour suppressor
  • 7. Clinical Features • Cutaneous Findings • Café-au-lait spots and other hyperpigmented skin lesions seen in 99% of adults with NF1. – Café-au-lait spots are pigmented, flat (macular) skin lesions typically with smooth edges. – Present at birth, they increase in size and number.
  • 8. • Other pigmented lesions include freckles (lentigines) • These areas of hyperpigmentation are present in axilla or groin.
  • 9. • Neurofibromas are benign nerve sheath tumors consisting of Schwann cells, fibroblastic elements, and embedded axons. – Solitary neurofibromas • Located on skin, especially on trunk, & face. • Arise in deep peripheral nerves, spinal nerve roots, and autonomic nerves of blood vessels. – Multiple neurofibromas are pathognomonic of NF1. – Plexiform neurofibroma, diffuse mass with extensive interdigitations with surrounding tissue.
  • 13. •Congenital glaucoma associated with upper eyelid neurofibroma. –Gonioscopy shows iris insertion anterior to scleral spur. –Angle appears to be covered by a membrane. •Optic nerve gliomas are pilocytic hamartomas of anterior visual pathways. –Bilateral optic nerve gliomas are pathognomonic of NF1. •Pulsatile exophthalmos due to sphenoid dysplasia . •Prominent corneal nerves. •Conjunctival and scleral neurofibroma are rare.
  • 17. MANAGEMENT • Patients need detailed counseling regarding the prognosis, genetic, and psychological aspects of disease. • First-degree relatives should be evaluated. • Malignant tumors : excision, chemotherapy, and/or radiotherapy may be indicated.
  • 18. • Management of optic nerve glioma remains controversial. –Therapeutic indication and outcomes with various forms of treatment include observation, chemotherapy, excision, and radiotherapy. • Long-term follow- up shows a good prognosis. • Chemotherapy may stabilize vision or induce tumor regression in more than 50% of cases.
  • 20. • Central NF • Unlike NF1,cutaneous findings are not predominant . • Schwannomas are the characteristic tumors of NF2.
  • 21. • Autosomal dominant • About 50% of cases represent new mutations. • Chromosome 22q12. – It encodes a protein known as schwannomin
  • 24. SYSTEMIC FINDINGS • Bilateral vestibular schwannomas (VS) are diagnostic of NF 2. • The mean age at onset of VS is less than 25 years • Symptoms of NF2 are due to VS rather than to ocular involvement. – Deafness with or without tinnitus is most common. Seizures, vertigo, and numbness are less common. – Blindness occurs as presenting symptom in only 1% of cases.
  • 25. • Spinal schwannomas are present in more than 75% of the cases with NF2. • Additionally, intracranial or optic nerve meningiomas and spinal ependymomas are also observed.
  • 27. OPHTHALMIC FINDINGS • Posterior subcapsular cataract or wedge cortical cataracts. • Retinal hamartoma and combined hamartomas of the retina and retinal pigment epithelium (RPE). • Rarely Lisch nodules
  • 30. MANAGEMENT • Patients should be screened by neurologic, ophthalmic, and neuro-otologic testing. • MRI (contrast-enhanced, multi planar T1- weighted) is a cost-effective first-line investigation in detection of VS. • Majority (90%) of patientspresent with bilateral VS. • Management of VS include observation, stereotactic radiotherapy, and surgical resection.
  • 32. • Eugen von Hippel, a German ophthalmologist, coined the term angiomatosis retinae in 1904. • Arvid Lindau, a Swedish pathologist, established a relationship between cerebellar and retinal hemangioblastomas
  • 33. • Autosomal dominant • VHL gene on chromosome 3p25-26
  • 35. SYSTEMIC FINDINGS • VHL disease is a multisystem disorder with a predilection for the retina and CNS. • Retinal capillary hemangiomas (RCH) occur in ‹ 75% of cases, CNS hemangiomas in more than 50%, renal carcinomas in ‹ 50% , and pheochromocytomas in ‹ 25%. • Probability of developing any components of disease increases with age.
  • 36. • Central nervous system hemangioma commonly involve cerebellum (75%) and spinal cord (15%). • Tend to be multiple and occur at a younger age as compared to sporadic cases. • Headache is initial symptom of cerebellar hemangiomas and pain is common symptom of spinal cord hemangiomas.
  • 38. • Renal cell carcinoma is leading cause of mortality. – Bilateral in 93% of cases; multiple, renal cysts, and occur at younger age compared to sporadic cases. • Pheochromocytomas, rare benign tumors of adrenal medulla, tend to be multiple and bilateral. – Elevated serum levels of catecholamines (norepinephrine and epinephrine) that lead to symptoms such as palpitations, headaches, and sweating.
  • 40. OPHTHALMOLOGIC FINDINGS • Retinal capillary hemangioma (RCH) is one of the most common manifestations • Circumscribed, round retinal lesion with an orange-red color with prominent feeder vessels. • Presence of multiple RCH (two or more), other manifestations of VHL disease, or a positive family history are diagnostic of underlying VHL disease.
  • 42. MANAGEMENT • Treatment of RCH determined by size, location, and associated subretinal fluid, retinal traction, and visual potential of eye. • Retinal angiomas can be effectively treated with cryotherapy or laser photocoagulation
  • 43. • Early diagnosis increases the likelihood of successful treatment yet the ocular lesions are asymptomatic prior to RD. • Should undergo periodic ophthalmologic evaluation beginning at about age 5 years. • Life expectancy may be improved by early detection and treatment of various tumors.
  • 45. • Coined by Desire Magloire Bourneville (1840–1909), a French physician. • He described a patient with seizures, hemiplegia, mental subnormality, and renal tumors. • He based the terminology tuberous sclerosis, on multiple potato-like (tubers) lesions in the brain
  • 46. GENETICS • Tuberous sclerosis complex (TSC) includes two genetic diseases (TSC1 and TSC2) with autosomal dominant inheritance or sporadic. • The genes responsible for TSC, TSC1 (chromosome 9q34)71 and TSC2,72 have now been identified. • TSC1 and TSC2 genes, encode the proteins hamartin and tuberin, respectively.
  • 48. SYSTEMIC FINDINGS • Characterized by hamartomas of various organs. • Hamartomas in the brain (astrocytoma and ependymoma) lead to childhood seizures and mental retardation.
  • 49. • Clinical manifestations of TSC1 and TSC2 are similar except that the TSC1 is milder with a reduced risk of mental retardation as compared to TSC2. • Other findings of TSC1 such as seizures, renal involvement, facial angiofibroma, and retinal hamartomas are also less frequent or less severe compared to TSC2.
  • 50. • Cutaneous manifestations of TSC are mainly of diagnostic significance. – Hypomelanotic macules are the most frequent and the earliest finding, best visualized with Wood’s lamp (UV light). – Fibrous plaques appear as reddish-orange patches on the forehead. – Facial angiofibromas are not present at birth and appear usually by age 5 years.
  • 53. • Visceral manifestations include pulmonary lymphangiomyomatosis, renal angiomyolipoma, and cardiac rhabdomyoma • Imaging studies such as MRI of brain and CT - abdomen are important to detect CNS and visceral involvement.
  • 54. • OPHTHALMOLOGIC FINDINGS • Retinal or Optic nerve hamartomas • Three morphologic types of retinal astrocytic hamartomas are opthlamoscopically recognized: 1. More common subtle, flat, round, semitranslucent lesion; 2. Large, elevated, nodular, and calcified mulberry lesion; 3. Mixed type of lesion, being calcified in the central portion and semitranslucent in the periphery.
  • 56. MANAGEMENT • Depends upon location & extent of organ involvement. • Retinal astrocytic hamartomas usually need only periodic evaluation by ophthalmoscopy and fundus photography. • Patients with TSC-related mental retardation require supervision for daily living.
  • 57. • Common causes of mortality are renal disease, brain tumors and status epilepticus. • Patients need lifelong follow-up for early detection of potentially life threatening complications.
  • 59. • Sturge (1879) reported the case of a child with facial “port-wine stain,” epilepsy, buphthalmos, and a dark choroid. • Schirmer had noted the association with glaucoma in 1860. • Weber (1922) reported brain X-ray findings of “railtrack” sign
  • 60. SYSTEMIC FINDINGS • Predominant manifestation is a diffuse hemangioma in leptomeninges, choroid, and facial skin. • Sturge–Weber syndrome with its neural involvement leads to intractable seizures, developmental delay, and behavioral problems.
  • 61. • Cutaneous manifestations of nevus flammeus, although most evident, are mainly of diagnostic significance, • Glaucoma and diffuse choroidal hemangioma may be associated with some visual loss.
  • 62. • Leptomeningeal hemangiomatosis is ipsilateral to cutaneous involvement. –This can lead to a seizure disorder due to effects on underlying cerebral cortex. –Contrast-enhanced MRI for detecting cerebral atrophy and leptomeningeal angiomatous malformations. –If MRI is normal, CT scan to detect intracranial calcifications.
  • 64. • Cutaneous hemangioma is also called nevus flammeus or port wine stain. – Only 10% are associated with SWS. – SWS only occurs in patients with, involvement of V1 or V2 distribution of trigeminal nerve. – Bilateral port wine stains have higher associatpon. • Leptomeningeal and ocular involvement in SWS are always associated with port wine stain involving eyelids.
  • 66. OPHTHALMOLOGIC FINDINGS • Glaucoma is the most frequent manifestation of SWS and occurs in 70% of all cases. • Angle maldevelopment or raised episcleral venous pressure can lead to glaucoma.
  • 67. • Incidence of glaucoma is higher if the eyelids are involved with nevus flammeus. • Choroidal hemangioma is usually unilateral and ipsilateral to the nevus flammeus. – Appears as an orange-colored, diffuse choroidal thickening associated with exudative RD.
  • 69. MANAGEMENT • Medical therapy of glaucoma is effective in some cases, but eventually require multiple trabeculectomies combined trabeculotomy with trabeculectomy, or even drainage implants. • Choroidal hemangioma can be treated with low- dose standard radiotherapy or with proton beam radiotherapy. • Seizures are generally controlled with medications but intractable cases require surgical resection of leptomeningeal angiomatosis with underlying cerebral cortex.
  • 71. • Madame Louis-Bar in 1941 described a young boy with progressive cerebellar ataxia and oculocutaneous telangiectasia. • Term ‘ataxia telangiectasia’ was proposed by Boder and Sedgwick in 1958 • Autosomal recessive. • Causative gene in AT is called ATM (ataxia - telangiectasia mutated gene) and is found on chromosome llq22.3.
  • 72. SYSTEMIC FINDINGS • Childhood neurodegenerative disorder with neural, ocular, and cutaneous manifestations associated with immune dysfunction. • Progressive cerebellar ataxia in early childhood is hallmark of AT • Show increased sensitivity to the tissue-damaging side effects of therapeutic radiation and chemotherapeutic agents.
  • 73. • Defective T-cell function associated with hypoplasia of the thymus and decreased levels of circulating immunoglobulin. • Recurrent respiratory tract infections are a serious problem, • Increased susceptibility to various malignancies, particularly lymphomas and leukemias, contributes to early mortality.
  • 74. Ocular findings • Telangiectasia of conjunctiva has later onset than ataxia and appears at age 3-7 years. • First noted in the interpalpebral bulbar conjunctiva away from limbus. • Later ocular telangiectasia becomes generalized and simulates a conjunctivitis.
  • 75. • Ocular abnormalities include oculomotor apraxia, deficient accommodation, impaired smooth pursuit, hypometric saccades,nystagmus, absence of optokinetic nystagmus, frequent blinking. • Combination of oculomotor apraxia and failure to suppress the vestibulo-ocular reflex is characteristic.
  • 76. • Patients will develop impairment of pursuits by school age. • Increased saccadic latency, saccadic hypometria, and saccadic intrusions are also seen. • Visual acuity, pupillary response, and funduscopic examination are usually normal.
  • 77. MANAGEMENT • AT patients suffer from recurrent sino- pulmonary infections because of immune dysfunction. • AT-associated malignancies such as lymphoma and leukemia require modified chemotherapy and radiotherapy dosages because of hypersensitivity to radiation and chemotherapy-induced DNA damage.